NDC 57664-429-18 - HYDROCHLOROTHIAZIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 57664-429
- Requested NDC
- 57664-429-18
- Package NDCs from labels
- 57664-429-88, 57664-429-13, 57664-429-18
- Manufacturer
- CARACO PHARMACEUTICAL LABORATORIES, LTD.
- Effective date
- 2007-03-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| HYDROCHLOROTHIAZIDE - CARACO PHARMACEUTICAL LABORATORIES, LTD. | CARACO PHARMACEUTICAL LABORATORIES, LTD. | 2007-03-27 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57664-429-13 | HYDROCHLOROTHIAZIDE | 500 in 1 BOTTLE | TABLET | 500 | 1 | |
| 57664-429-18 | HYDROCHLOROTHIAZIDE | 1000 in 1 BOTTLE | TABLET | 1000 | 1 | |
| 57664-429-88 | HYDROCHLOROTHIAZIDE | 100 in 1 BOTTLE | TABLET | 100 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 57664-429-18 | EA - Each | 57664-429 | 6533aca0-8387-4075-bde6-d199d7fb015a | 1 | 2013-02-13 |
| 57664-429-88 | EA - Each | 57664-429 | d65bfc6a-2427-4016-80b2-bb1a52c09ad5 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Solco Healthcare U.S., LLC | 60c97ab9-b25e-4ea5-a159-792292178c65 | 2020-05-20 | Warnings, Adverse reactions | 310798 197770 |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | ScieGen Pharmaceuticals, Inc. | 02e96a51-1d56-460c-8c20-3d6f37e0ce46 | 2020-05-11 | Warnings, Adverse reactions | 310798 197770 |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Exelan Pharmaceuticals Inc. | b5a1b38c-0433-4649-a8b0-f72db0a96c45 | 2018-12-28 | Warnings, Adverse reactions | 310798 197770 |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Aphena Pharma Solutions - Tennessee, LLC | 61487122-8a94-4ad5-a307-7893e0b7510c | 2017-10-13 | Warnings, Adverse reactions | 310798 197770 |
| 19590BF0-BECF-5A55-C964-1642916113FA | 7b38ac8a-4540-4eb2-aedd-9aa966d22190 | 2007-03-27 | Warnings, Adverse reactions | 19590BF0-BECF-5A55-C964-1642916113FA 7b38ac8a-4540-4eb2-aedd-9aa966d22190 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.